TLR2 and gastric cancer: The analysis of the expression of the studied TLR-2, -3, -4, and -9 in the genetic material of sorted CD3-CD56+ and CD3+CD56+cells from patients with diffuse and intestinal GC and HV showed significant differences in the expression level.